Endometrial cancer – Life with Disease

Go back

Endometrial cancer is a type of cancer that begins in the lining of the uterus, called the endometrium, and represents the most common gynecologic cancer affecting women in the United States. Understanding how this disease progresses, what complications may arise, and how it affects daily life can help patients and families navigate the challenges ahead with greater confidence and clarity.

Prognosis and Survival Outlook

The outlook for someone diagnosed with endometrial cancer depends on several important factors, including the stage at which the cancer is discovered, the type of cancer cells involved, and the person’s overall health. Many people find endometrial cancer at an early stage because it often causes noticeable symptoms, particularly irregular vaginal bleeding. This early detection is one reason why many patients have a favorable outlook compared to other types of cancer.[1]

When endometrial cancer is found early and remains confined to the uterus, surgical removal of the uterus often provides successful treatment. However, the prognosis varies significantly depending on how far the cancer has spread. Stage I and Stage II cancers, which have not moved beyond the uterus or cervix, generally have better outcomes than Stage III and Stage IV cancers, which have spread to other areas such as the vagina, ovaries, lymph nodes, or distant organs like the bladder.[2][8]

The type of endometrial cancer also matters greatly. Type 1 endometrial cancers, which make up about 80 percent of all cases and grow slowly, tend to have a more favorable prognosis. Type 2 cancers, including serous and clear cell types, grow more aggressively and are more likely to spread to other parts of the body, making them more challenging to treat.[4][6]

It’s important to understand that survival statistics represent averages from large groups of people and cannot predict what will happen to any individual person. Each person’s cancer is unique, and factors such as age, general health, response to treatment, and genetic characteristics of the cancer cells all play a role in determining outcomes.[2]

⚠️ Important
Despite advances in treatment, endometrial cancer is one of the few cancers where survival rates have decreased slightly over the past decade. The overall mortality from uterine cancer has increased by approximately 1.7 percent over the past ten years. This trend highlights the importance of early detection, prompt treatment, and ongoing research into more effective therapies.[13]

Natural Progression Without Treatment

If endometrial cancer goes untreated, the abnormal cells in the lining of the uterus continue to multiply and grow without control. This uncontrolled growth forms a mass or tumor that gradually expands within the endometrium. As the cancer cells accumulate, they can invade deeper layers of the uterine wall, moving from the inner lining into the muscular middle layer called the myometrium.[5]

Over time, untreated endometrial cancer does not remain confined to the uterus. Cancer cells can spread beyond the uterus to nearby structures such as the cervix, which connects the uterus to the vagina. From there, the cancer may extend to the vagina itself, the ovaries, and the fallopian tubes. This local spread represents progression from early-stage disease to more advanced stages.[8]

As the disease advances further, cancer cells can enter the lymphatic system, which is a network of vessels and nodes that helps the body fight infection. Once cancer cells reach the lymph nodes in the pelvis and abdomen, they can travel to more distant parts of the body. This process, called metastasis, means the cancer has spread far from where it started. Advanced endometrial cancer can metastasize to organs such as the bladder, bowel, lungs, liver, and bones.[2][8]

The speed at which endometrial cancer progresses varies considerably among individuals and depends on the type of cancer cells involved. Type 1 cancers tend to grow slowly over months or years, while Type 2 cancers can progress much more rapidly and aggressively. Without intervention, the expanding tumor causes increasingly severe symptoms, including heavy vaginal bleeding, persistent pelvic pain, unintended weight loss, and general weakness.[4][6]

Possible Complications

Endometrial cancer and its treatments can lead to several complications that affect both physical health and quality of life. Some complications arise directly from the cancer itself, while others result from the treatments used to fight the disease. Understanding these potential challenges helps patients and families prepare and seek appropriate support.

One significant complication is the spread of cancer to nearby organs. When endometrial cancer invades the bladder, it can cause difficult or painful urination, blood in the urine, and frequent urinary tract infections. If the cancer spreads to the bowel, it may lead to changes in bowel habits, abdominal pain, and intestinal blockages. These complications require additional medical interventions and can significantly impact daily comfort and function.[2]

Abnormal vaginal bleeding is both a symptom and a complication of endometrial cancer. As the cancer grows, bleeding may become heavier and more frequent, potentially leading to anemia, which is a condition where the blood doesn’t carry enough oxygen throughout the body. Anemia causes fatigue, weakness, dizziness, and shortness of breath, making it difficult to carry out normal activities.[1][5]

Pain is another common complication. As the tumor grows and presses on surrounding tissues and nerves, patients may experience persistent pelvic pain or cramping. Pain during sexual intercourse may also occur, affecting intimate relationships and emotional well-being. Advanced cancer that has spread to bones or other organs can cause pain in those areas as well.[5]

Treatment-related complications are also important to consider. Surgery to remove the uterus, called hysterectomy, is the most common treatment for endometrial cancer. This surgery results in permanent infertility and triggers immediate menopause in women who have not yet gone through this transition naturally. Surgical menopause can cause sudden and severe symptoms such as hot flashes, night sweats, mood changes, and vaginal dryness.[10][12]

Radiation therapy, chemotherapy, and hormone therapy each carry their own potential complications. Radiation can cause damage to nearby organs, leading to bowel problems, bladder irritation, and vaginal changes. Chemotherapy may cause nausea, vomiting, hair loss, fatigue, and increased risk of infections due to lowered blood cell counts. These side effects can be temporary or long-lasting, depending on the intensity and duration of treatment.[11][12]

Some women with endometrial cancer develop lymphedema, which is swelling in the legs caused by damage to lymph nodes during surgery or radiation. Lymphedema can be uncomfortable, limit mobility, and increase the risk of infections in the affected limb. This condition may persist long after treatment has ended and requires ongoing management.[11]

Emotional and psychological complications should not be overlooked. The diagnosis of cancer, the stress of treatment, changes to body image, loss of fertility, and uncertainty about the future can all contribute to anxiety, depression, and emotional distress. These mental health challenges affect not only the patient but also their family members and caregivers.[19][20]

Impact on Daily Life

Living with endometrial cancer affects nearly every aspect of a person’s daily life, from physical capabilities to emotional well-being, social relationships, work responsibilities, and personal interests. The disease itself and its treatments create challenges that require adjustments, support, and resilience.

Physical symptoms such as vaginal bleeding, pelvic pain, and fatigue can make it difficult to maintain normal routines. Heavy bleeding may require frequent changes of sanitary protection and can cause embarrassment or anxiety about being in public places. Fatigue, which can result from the cancer itself, anemia, or treatment side effects, leaves many people feeling exhausted even after adequate rest. Simple tasks like grocery shopping, housework, or climbing stairs may become overwhelming.[19][20]

Treatment schedules often demand significant time and energy. Appointments with doctors, surgical procedures, radiation sessions, and chemotherapy infusions require patients to reorganize their calendars, sometimes for weeks or months. Travel to treatment centers, waiting times, and recovery periods between treatments all consume time that would otherwise be spent on work, family, or leisure activities.[19]

Work life is frequently disrupted. Some patients need to reduce their hours, take extended leave, or stop working altogether during intensive treatment periods. The physical demands of certain jobs may become impossible to meet. Financial concerns arise when income decreases while medical expenses increase, adding stress to an already challenging situation. Patients may need to apply for disability benefits or seek financial assistance programs.[20]

Relationships with family and friends can change in complex ways. While many loved ones provide essential support, others may struggle to understand what the patient is experiencing or may not know how to help. Some patients feel guilty about burdening their families or frustrated when others seem uncomfortable discussing the illness. Sexual intimacy often becomes difficult or impossible due to physical symptoms, surgical changes to the body, and emotional stress.[19][20]

Body image and self-esteem may suffer. Surgical removal of the uterus marks the permanent end of fertility, which can be particularly devastating for younger women who hoped to have children. Even for those who have completed their families, the loss of reproductive organs can affect how they view their femininity and identity. Hair loss from chemotherapy, weight changes, and surgical scars further alter physical appearance.[20]

Emotional well-being fluctuates throughout the cancer journey. Fear, sadness, anger, guilt, and anxiety are all normal responses to a cancer diagnosis. Patients worry about their prognosis, the effectiveness of treatment, the possibility of recurrence, and how their illness affects their loved ones. Some days feel manageable, while others bring overwhelming emotions. This emotional rollercoaster is exhausting and adds to the overall burden of the disease.[19][20]

⚠️ Important
Coping with endometrial cancer requires a multifaceted approach. Maintaining healthy habits such as eating nutritious foods, staying physically active within your abilities, getting adequate rest, and staying hydrated can help your body heal and maintain strength. Reaching out for professional counseling, joining support groups, and staying connected with family and friends provides essential emotional support. Being honest with yourself about your feelings and allowing yourself to experience them without judgment is an important part of the healing process.[19][20]

Hobbies and leisure activities may need to be modified or temporarily set aside. Patients who enjoyed physical activities like hiking, gardening, or sports may find these too demanding during treatment. Creative pursuits that require concentration might feel impossible when dealing with “chemobrain,” a term used to describe the cognitive fog that often accompanies chemotherapy. Finding new, less demanding activities or adapting favorite hobbies to current capabilities can help maintain a sense of normalcy and joy.[22]

Planning for the future becomes complicated. Uncertainty about prognosis makes it difficult to make long-term plans, whether for travel, career advancement, or family events. Some patients find it helpful to focus on short-term goals and live one day at a time, while others need to make practical arrangements for the possibility of their condition worsening.[21]

Support for Families and Clinical Trials

Families play a crucial role in supporting loved ones with endometrial cancer, and understanding how to help can make a significant difference. Clinical trials represent an important treatment option that families should know about and may help their loved ones access.

Clinical trials are research studies that test new treatments, combinations of existing treatments, or different ways of delivering therapy. These studies are essential for advancing medical knowledge and improving care for future patients. For someone with endometrial cancer, participating in a clinical trial may provide access to cutting-edge treatments that are not yet widely available. Trials may involve new chemotherapy drugs, immunotherapy approaches, targeted therapies, or innovative combinations of existing treatments.[16][17]

Recent advances in endometrial cancer treatment have come through clinical trials. For example, immune checkpoint inhibitors, which help the body’s immune system recognize and attack cancer cells, have been approved for treating advanced endometrial cancer based on clinical trial results. Targeted therapies that block specific proteins cancer cells use to grow have also emerged from research studies. These breakthroughs offer hope for patients whose cancer has not responded to traditional treatments or has returned after initial therapy.[16][17]

Family members can help by researching clinical trials that might be appropriate for their loved one’s specific situation. Several online databases and cancer organization websites allow searches based on cancer type, stage, and location. Bringing information about relevant trials to medical appointments gives the healthcare team the opportunity to discuss whether participation might be beneficial. It’s important to understand that joining a clinical trial is always voluntary, and patients can withdraw at any time.[2][16]

When considering a clinical trial, families should help their loved one understand what participation involves. This includes asking questions about the purpose of the study, what treatments will be given, how the treatment differs from standard care, what side effects might occur, how often visits are required, and whether there are any costs. Genetic counselors and patient navigators can provide valuable guidance in making these decisions.[19]

Beyond clinical trials, families can support their loved ones in many practical and emotional ways. Accompanying patients to appointments provides companionship and an extra set of ears to remember what doctors say. Taking notes during medical visits helps keep track of important information. Families can assist with transportation to treatments, help manage medications, prepare nutritious meals, and handle household tasks when the patient is too tired or unwell.[19][20]

Emotional support is equally important. Simply being present, listening without judgment, and offering comfort during difficult moments can be profoundly meaningful. Families should be patient with their loved one’s changing moods and needs, recognizing that the cancer journey involves many ups and downs. Encouraging open communication about fears, hopes, and practical concerns helps everyone feel more connected and less isolated.[19][20]

Caregivers also need to take care of themselves. The stress of supporting someone with cancer can be overwhelming, leading to burnout, depression, and health problems. Families should seek their own support through counseling, caregiver support groups, or respite care services that provide temporary relief from caregiving responsibilities. Maintaining personal health, staying connected with friends, and taking breaks are essential for sustaining the ability to provide good care over time.[19]

Understanding the healthcare team is another way families can help. The team typically includes gynecologic oncologists who specialize in treating cancers of the reproductive system, medical oncologists who manage chemotherapy and other drug treatments, radiation oncologists, oncology nurses, social workers, patient navigators, registered dietitians, and genetic counselors. Each team member has specific expertise that contributes to comprehensive care. Families can help coordinate communication between different specialists and ensure that all team members have complete information about the patient’s condition and treatments.[19]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Dostarlimab-gxly (Jemperli) – An immune checkpoint inhibitor approved for treating advanced endometrial cancer, helping the immune system recognize and attack cancer cells
  • Durvalumab (Imfinzi) – An immune checkpoint inhibitor approved for treating advanced endometrial cancer, blocking proteins that prevent immune response against cancer
  • Pembrolizumab (Keytruda) – An immune checkpoint inhibitor approved for treating advanced endometrial cancer, used alone or in combination with other therapies
  • Lenvatinib (Lenvima) – A targeted therapy that blocks proteins cancer cells use to grow and form blood vessels, typically used with pembrolizumab
  • Tamoxifen – While primarily used for breast cancer treatment, it can increase the risk of endometrial cancer and requires monitoring

Ongoing Clinical Trials on Endometrial cancer

  • Study of Disitamab Vedotin for Adults with Previously Treated HER2-Positive Solid Tumors, Including Lung, Head and Neck, Ovarian, and Endometrial Cancers

    Not yet recruiting

    2 1 1
    Investigated drugs:
    France Germany Italy Spain
  • Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

    Not recruiting

    2 1 1
    Investigated drugs:
    Belgium Denmark France Italy Spain
  • Study Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study of Giredestrant for Patients with Grade 1 Endometrial Cancer

    Not recruiting

    2 1 1
    Investigated drugs:
    Italy Poland
  • A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

    Not recruiting

    2 1 1
    Germany The Netherlands Spain
  • Study on the Effectiveness of Biomarker Staging Compared to Conventional Staging in Women with Early-Stage Endometrial Cancer Using Paclitaxel and Carboplatin

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer

    Not recruiting

    2 1 1 1
    Belgium France The Netherlands Spain
  • Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

    Not recruiting

    2 1 1 1
    Belgium France Poland Spain
  • Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Italy Poland Spain

References

https://www.mayoclinic.org/diseases-conditions/endometrial-cancer/symptoms-causes/syc-20352461

https://www.cancer.gov/types/uterine/patient/endometrial-treatment-pdq

https://www.cancer.org/cancer/types/endometrial-cancer/about/what-is-endometrial-cancer.html

https://www.ncbi.nlm.nih.gov/books/NBK525981/

https://my.clevelandclinic.org/health/diseases/16409-uterine-cancer

https://www.acog.org/womens-health/faqs/endometrial-cancer

https://www.mdanderson.org/cancer-types/endometrial-cancer.html

https://www.cdc.gov/uterine-cancer/about/index.html

https://www.cancerresearchuk.org/about-cancer/womb-cancer

https://www.mayoclinic.org/diseases-conditions/endometrial-cancer/diagnosis-treatment/drc-20352466

https://www.cancer.org/cancer/types/endometrial-cancer/treating.html

https://www.sgo.org/patient-resources/uterine-cancer/uterine-cancer-treatment-options/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9978763/

https://www.cancer.gov/types/uterine/patient/endometrial-treatment-pdq

https://www.facingourrisk.org/info/risk-management-and-treatment/cancer-treatment/by-cancer-type/endometrial/stages-and-standard-therapy

https://www.myendometrialcancerteam.com/resources/new-treatments-for-endometrial-cancer-questions-to-ask-your-doctor

https://www.mdanderson.org/cancer-types/endometrial-cancer/endometrial-cancer-treatment.html

https://my.clevelandclinic.org/health/diseases/16409-uterine-cancer

https://www.spotherforec.com/living-with-endometrial-cancer

https://ourwayforward.com/endometrial-cancer/living-with-endometrial-cancer/

https://www.cancer.org/cancer/types/endometrial-cancer/after-treatment/follow-up.html

https://www.myendometrialcancerteam.com/resources/eating-well-with-advanced-endometrial-cancer-foods-to-eat-and-to-avoid

https://www.mdanderson.org/cancerwise/-how-i-knew-i-had-endometrial-cancer—six-survivors-share-their-symptoms-stories.h00-159621801.html

https://www.cancercare.org/diagnosis/endometrial_cancer

https://www.cedars-sinai.org/health-library/diseases-and-conditions/e/endometrial-cancer-overview.html

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

What is the most common symptom of endometrial cancer?

The most common symptom is abnormal vaginal bleeding, particularly bleeding after menopause or irregular bleeding between periods in premenopausal women. Any unexpected vaginal bleeding should be evaluated by a healthcare provider, as early detection significantly improves outcomes.

Can endometrial cancer be cured?

When endometrial cancer is found early and confined to the uterus, surgical removal of the uterus often successfully treats the disease. The prognosis depends on the stage at diagnosis, the type of cancer cells, and the patient’s overall health. Early-stage cancers generally have favorable outcomes.

What are the main risk factors for developing endometrial cancer?

Major risk factors include obesity, older age, never having given birth, early menstruation, late menopause, polycystic ovary syndrome, type 2 diabetes, taking estrogen without progesterone, taking tamoxifen for breast cancer, and having genetic conditions like Lynch syndrome. Many risk factors involve prolonged exposure to estrogen without progesterone.

Will I be able to have children after treatment for endometrial cancer?

The standard treatment for endometrial cancer is hysterectomy, which involves removing the uterus and results in permanent infertility. For young women who wish to preserve fertility, some early-stage cases may be treated with hormone therapy instead, though this is only appropriate in specific situations and requires careful discussion with a gynecologic oncologist.

What new treatments are available for endometrial cancer?

Recent advances include immune checkpoint inhibitors such as dostarlimab-gxly, durvalumab, and pembrolizumab, which help the immune system fight cancer. Targeted therapies like lenvatinib block specific proteins cancer cells need to grow. These newer treatments are particularly important for advanced or recurrent cancers and are often used in combination with chemotherapy.

🎯 Key takeaways

  • Endometrial cancer often causes vaginal bleeding early, which leads to early detection and better treatment outcomes compared to many other cancers
  • Surgery to remove the uterus is the most common treatment and can cure the disease when caught early
  • Type 1 endometrial cancers grow slowly and represent 80 percent of cases, while Type 2 cancers are more aggressive but less common
  • New immunotherapy and targeted therapy drugs approved in 2024 offer promising options for advanced and recurrent disease
  • Obesity is one of the biggest risk factors for endometrial cancer, related to hormonal changes caused by excess body fat
  • Clinical trials provide access to cutting-edge treatments not yet widely available and contribute to advancing care for future patients
  • Living with endometrial cancer affects physical health, emotional well-being, relationships, work, and daily routines, requiring comprehensive support
  • Family members play a crucial role in supporting patients through appointments, treatments, daily tasks, and emotional challenges while also needing to care for themselves

Connected medications: